The Wetling W200 is the only approved medical device that provides Wireless Micro Current Stimulation (WMCS) for wound and tissue healing.
The Wetling W200 device is intended to be used in professional health care environments for delivery of Wireless Micro Current Stimulation (WMCS) to patients. Without direct contact to the injured tissue, WMCS promotes and accelerates wound and tissue healing by attracting the cells of repair, changing cell membrane permeability, enhancing cellular secretion through cell membranes, and orienting cell structures through the bioelectrical process of electrotaxis.
The Wetling W200 device is suitable for WMCS treatment of most types of wounds and injuries, both chronic and acute:
The Wetling W200 device has the following main benefits as compared to conventional wound care:
Do not use the Wetling W200 if:
The performance, efficacy and safety of the Wetling W200 have been validated in various clinical trials, case reports and case studies. The clinical evidence is summarized in an independently authored Clinical Evaluation Report (CER), based on 127 articles and other publications.
The CER is available upon request to health care practitioners and other specialists that are interested in delving further into the scientific evidence on which this groundbreaking new product is based.
Europe | MDD 93/42/EEC | Class IIa |
Australia | ARTG | Class IIa |
Singapore | HSA | Class B |
Malaysia | MDA | Class B |
Indonesia | MOH | Class B |
New Zealand | WAND | Class IIa |
Thailand | Thai FDA | Class 2 |
In addition, the Wetling company is certified as per ISO 13485:2016 for the Production, distribution sales and service of active medical devices for wound healing by TÜV SÜD in Munich, Germany.